ADVANCED CERVICAL ADENOSQUAMOUS CARCINOMA

Clinical trials for ADVANCED CERVICAL ADENOSQUAMOUS CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new ADVANCED CERVICAL ADENOSQUAMOUS CARCINOMA trials appear

Sign up with your email to follow new studies for ADVANCED CERVICAL ADENOSQUAMOUS CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

First human test of oral cancer drug seeks to boost radiation power

Disease control Ongoing

This early-stage study is testing a new oral drug called Triapine, given alongside standard chemotherapy (cisplatin) and radiation for advanced cervical or vaginal cancer. The main goals are to find the safest and most effective dose of Triapine and to see how well the body absor…

Matched conditions: ADVANCED CERVICAL ADENOSQUAMOUS CARCINOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

ADVANCED CERVICAL ADENOSQUAMOUS CARCINOMA

Get alerted when new ADVANCED CERVICAL ADENOSQUAMOUS CARCINOMA trials appear

First human test of oral cancer drug seeks to boost radiation power